Profile
| Metric | Value |
|---|---|
| Full Name | Exact Sciences Corporation |
| Ticker | NASDAQ: EXAS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | exactsciences.com |
| Employees | 6,900 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $102.11 | |
| Price, 1D Change | +0.32% | |
| Market Cap | $19B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.75 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +10.37% | |
| EPS | -$5.59 | |
| EPS, 1Y Change | -392.91% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$5.59 | |
| EPS Estimate | $0.34 | |
| EPS Est. Change | +106.05% | |
| Revenue | $2.76B | |
| Revenue Estimate | $3.23B | |
| Revenue Est. Change | +17.06% | |
| Current Price | $102.11 | |
| Price Target | - | $105.00 |
| Price Tgt. Change | - | +2.83% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.35 | -$1.13 | +16.06% | |
| -$0.57 | -$5.59 | -884.94% | |
| $0.34 | N/A | +106.05% | |
| $1.12 | N/A | +120.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.49B | $2.50B | +0.35% | |
| $2.75B | $2.76B | +0.45% | |
| $3.23B | N/A | +17.06% | |
| $3.67B | N/A | +32.95% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +80.15% | |
| Price, 3Y | +73.60% | |
| Market Cap, 1Y | +83.89% | |
| Market Cap, 3Y | +84.86% | |
| Revenue, 1Y | +10.37% | |
| Revenue, 3Y | +56.13% | |
| EPS, 1Y | -392.91% | |
| EPS, 3Y | -60.69% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $102.11 | |
| SMA 200 | $61.37 | |
| SMA 200 vs Price | -39.90% | |
| SMA 50 | $90.80 | |
| SMA 50 vs Price | -11.08% | |
| Beta | 0.75 | |
| ATR | $0.73 | |
| 14-Day RSI | 81.90 | |
| 10-Day Volatility | 3.25% | |
| 1-Year Volatility | 48.41% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.76B | |
| EPS | -$5.59 | |
| Gross Profit | $1.92B | |
| Gross Margin | 69.55% | |
| Operating Profit | -$191.79M | |
| Operating Margin | -6.95% | |
| Net Income | -$1.03B | |
| Net Margin | -37.29% | |
| EBITDA | $23.07M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.16 | |
| Current Ratio | 2.15 | |
| Quick Ratio | 1.92 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 2.57 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 6.28 | |
| PB Ratio | 7.73 | |
| EV/EBITDA | 213.93 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $2.40B | |
| Cash & Equivalents | $1.04B | |
| Total Assets | $6.17B | |
| Current Assets | $1.57B | |
| Total Liabilities | $3.77B | |
| Current Liabilities | $732.19M | |
| Total Debt | $2.78B | |
| Short Term Debt | $284.36M | |
| Accounts Payable | $89.57M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $3.79B | |
| Operating Expenses | $2.11B | |
| Cost Of Goods Sold | $840.15M | |
| SG&A | $0.00 | |
| D&A | $214.86M | |
| Interest Expense | $0.00 | |
| Income Tax | -$7.30M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $210.54M | |
| CFI | -$442.16M | |
| CFF | $231.87M | |
| Capex | $135.99M | |
| Free Cash Flow | $74.55M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| Stifel | → | |
| Canaccord Genuity | → | |
| Jefferies | → | |
| Benchmark | → | |
| William Blair | → | |
| Wells Fargo | → | |
| Guggenheim | → | |
| Barclays | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with EXAS
Data Sources & References
- EXAS Official Website www.exactsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414025000091/0001124140-25-000091-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414025000020/0001124140-25-000020-index.htm
- EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
- EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas
FAQ
What is the ticker symbol for Exact Sciences Corporation?
The ticker symbol for Exact Sciences Corporation is NASDAQ:EXAS
Does Exact Sciences Corporation pay dividends?
No, Exact Sciences Corporation does not pay dividends
What sector is Exact Sciences Corporation in?
Exact Sciences Corporation is in the Healthcare sector
What industry is Exact Sciences Corporation in?
Exact Sciences Corporation is in the Diagnostics & Research industry
What country is Exact Sciences Corporation based in?
Exact Sciences Corporation is headquartered in United States
When did Exact Sciences Corporation go public?
Exact Sciences Corporation initial public offering (IPO) was on February 1, 2001
Is Exact Sciences Corporation in the S&P 500?
No, Exact Sciences Corporation is not included in the S&P 500 index
Is Exact Sciences Corporation in the NASDAQ 100?
No, Exact Sciences Corporation is not included in the NASDAQ 100 index
Is Exact Sciences Corporation in the Dow Jones?
No, Exact Sciences Corporation is not included in the Dow Jones index
When was Exact Sciences Corporation last earnings report?
Exact Sciences Corporation's most recent earnings report was on November 3, 2025
When does Exact Sciences Corporation report earnings?
The next expected earnings date for Exact Sciences Corporation is February 25, 2026